Innovation Pharmaceuticals Inc.
IPIX
$0.0002
$0.000.00%
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | 59.15% | 55.01% | 48.46% | 53.12% | 56.54% |
| Total Depreciation and Amortization | -1.58% | -2.36% | -1.31% | -0.79% | 0.26% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -74.24% | -49.53% | 204.89% | -53.59% | -80.93% |
| Change in Net Operating Assets | 525.00% | 183.33% | 139.09% | 119.73% | 98.94% |
| Cash from Operations | 61.07% | 66.46% | 65.99% | 62.77% | 48.46% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 98.57% | 98.53% | -5,810.14% | -5,471.23% | -4,629.07% |
| Cash from Investing | 98.57% | 98.53% | -5,810.14% | -5,471.23% | -4,629.07% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 97.02% | 96.42% | 99.02% | 98.78% | -427.41% |
| Issuance of Common Stock | -- | -- | -100.00% | -100.00% | -98.69% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -100.00% | -100.00% | -84.60% |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -26.32% | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -105.71% | -103.10% | -102.17% | -100.79% | -93.23% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 74.46% | 64.16% | -62.56% | -533.72% | -308.35% |